| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,334,000 | 3,201,000 | 3,904,000 | 3,245,000 | | Cost of Revenue | 1,455,000 | 1,010,000 | 4,633,000 | 1,386,000 | | | Gross Profit | 1,879,000 | 2,191,000 | (729,000) | 1,859,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 945,000 | 778,000 | (1,976,000) | 961,000 | | Non Recurring |
-
| 261,000 | (58,000) | (98,000) | | Others | 588,000 | 435,000 | 459,000 | 414,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 346,000 | 717,000 | 846,000 | 582,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | 2,000 | 76,000 | 16,000 | | Earnings Before Interest And Taxes | 335,000 | 719,000 | 922,000 | 598,000 | | Interest Expense | 166,000 | 195,000 | 213,000 | 175,000 | | Income Before Tax | 169,000 | 524,000 | 709,000 | 423,000 | | Income Tax Expense | 54,000 | 192,000 | 238,000 | 160,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 115,000 | 332,000 | 471,000 | 263,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 115,000 | 332,000 | 471,000 | 263,000 | | Preferred Stock And Other Adjustments | 4,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $119,000 | $332,000 | $471,000 | $263,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
